Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 24, 2019
Sterling Pharma Solutions, has received a Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales.
read more
Wednesday, April 24, 2019
EpimAb Biotherapeutics announced the USPTO has granted the U.S. Patent No. 10,266,608 entitled “Fabs-In-Tandem Immunoglobulin and Uses Thereof.”
read more
Yposkesi announces the appointment of Morad El Gueddari as production director, gene therapy operations.
read more
Cambrex announced that it has opened a new 120m2 quality control (QC) laboratory at its site in Paullo, Milan, Italy.
read more
Bioclinica® has assembled a team of experts dedicated to NAFLD and NASH to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.
read more
Catalent announced that work is underway to expand integrated turnkey softgel capabilities at its facility in Eberbach, Germany.
read more
Adare Pharmaceuticals has entered into an agreement with Egalet, to acquire global rights of the “Parvulet™” technology platform and its associated Intellectual Property.
read more
Thermo Fisher Scientific and NX Prenatal have entered into a collaboration to develop clinical mass spectrometry-based proteomics assays to monitor fetal health in utero and assess the risk of adverse outcomes, including preterm birth and ...
read more
Almac Group has announced additional expansion plans at its Athlone facility.
read more
Recro Pharma announced its CDMO division, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.
read more
Ology Bioservices announced the Department of Defense has awarded the company with two contracts valued at $135.4 million.
read more
Dr. Reddy’s Laboratories has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in the U.S.
read more
Pulmatrix and Cipla announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole™, an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole.
read more
Paragon Bioservices announced it will be exploring the formation of a wide-ranging partnership in gene therapy manufacturing with Sarepta Therapeutics.
read more
HitGen announced it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ.
read more